Abdel-Magid, A. F. (2014). Inhibitors of Factor XIa and Plasma Kallikrein May Treat Thromboembolic Disorders and Many Diabetes Complications. American Chemical Society.
シカゴスタイル引用形Abdel-Magid, Ahmed F. Inhibitors of Factor XIa and Plasma Kallikrein May Treat Thromboembolic Disorders and Many Diabetes Complications. American Chemical Society, 2014.
MLA引用形式Abdel-Magid, Ahmed F. Inhibitors of Factor XIa and Plasma Kallikrein May Treat Thromboembolic Disorders and Many Diabetes Complications. American Chemical Society, 2014.
警告: この引用は必ずしも正確ではありません.